Veralto Corporation filings document the regulatory record for a Delaware operating company focused on essential water and product quality solutions. Form 8-K reports furnish quarterly and annual operating results, non-GAAP measures, cash flow commentary, completed acquisitions, cost optimization actions and other material events.
Its proxy and governance filings cover annual meeting proposals, director elections, executive compensation and shareholder voting matters. Other current reports address capital-structure actions such as common-stock repurchase authorizations, officer transitions, compensatory arrangements and related governance disclosures.
Veralto Corp (VLTO) officer Surekha Trivedi reported a proposed sale of 36,427 common shares on October 30, 2026, with an aggregate market value of $3,966,536.03. Fidelity Brokerage Services LLC is listed in the sale details, along with NYSE. The shares are listed as acquired from the issuer through a stock option exercise for cash. Trivedi also reported selling 986 common shares on August 17, 2026, for $95,691.30 during the preceding three months.
Veralto Corporation (VLTO) reported third-quarter 2026 sales of $1.509 billion, up 7.5% from $1.404 billion, and net earnings of $253 million versus $239 million. Core sales growth was 5.1%; management attributed growth to pricing and higher volume, with acquisitions also contributing to reported sales. Operating profit was $298 million versus $326 million, and operating margin was 19.7% versus 23.2%; gross margin was 60.2% versus 60.1%.
For the nine months, sales were $4.405 billion versus $4.107 billion and net earnings were $748 million versus $686 million. Operating cash flow was $845 million versus $766 million. Veralto repurchased approximately 6 million shares for $523 million during the period; $227 million remained under its $750 million repurchase authorization as of October 2, 2026.
After quarter-end, Veralto completed the $465 million acquisition of Cleanwater1, subject to customary post-closing adjustments, using commercial paper and cash on hand; Cleanwater1 will join Water Quality. Its cost optimization program is expected to incur $85 million to $105 million of charges and be substantially completed by the end of 2028.
Veralto Corp. reported third-quarter 2026 sales of $1,509 million, up 7.5% year over year; non-GAAP core sales growth was 5.1%. GAAP net earnings were $253 million, or $1.03 per diluted share, while non-GAAP adjusted net earnings were $290 million, or $1.18 per diluted share. Adjusted operating profit margin was 25.6%, compared with 23.9% a year earlier, and adjusted diluted earnings per share increased 19.2% year over year.
Operating cash flow was $323 million and non-GAAP free cash flow was $304 million. Veralto expects fourth-quarter non-GAAP core sales growth of 5.5% to 6.5%, adjusted operating profit margin of approximately 24.5%, and adjusted diluted earnings per share of $1.13 to $1.16. It raised full-year 2026 guidance to non-GAAP core sales growth of 4.2% to 4.5%, adjusted operating profit margin expansion of approximately 50 basis points, adjusted diluted earnings per share of $4.49 to $4.52, and a free cash flow to net earnings conversion ratio greater than 105%.
Year to date as of October 28, 2026, Veralto reported deploying $1.1 billion on four strategic acquisitions and repurchasing $550 million of shares, equal to 2.4% of shares outstanding as of February 13, 2026. Expected full-year savings from its Cost Optimization Program are now $10 million to $15 million.
On October 23, 2026, Veralto Corp (VLTO) President and CEO Jennifer Honeycutt exercised fully vested options covering 7,098 common shares at an exercise price of $28.76 per share and sold 7,098 common shares at $105.00 per share. Both transactions were made under a Rule 10b5-1 trading plan adopted February 25, 2026.
Veralto Corp (VLTO) is the issuer for Jennifer L. Honeycutt’s proposed sale of 7,098 common shares, with an aggregate market value of $745,290.00. Fidelity Brokerage Services LLC is listed as broker, and October 23, 2026 is the approximate sale date.
Honeycutt is also reported to have sold 7,097 common shares on July 29, 2026, with an aggregate market value of $720,487.44.
Veralto Corp President and CEO Jennifer Honeycutt reported two direct common-stock dispositions on October 20, 2026: 3,551 shares and 474 shares delivered or withheld for payment of exercise price or tax liability. The footnotes say the shares were acquired upon vesting and settlement of restricted stock units, with the transactions deemed effectuated by the plan administrator on that date. The reported $94.68 per-share amount reflects the applicable closing price available on October 2, 2026.
Veralto Corp (VLTO) reported that officer Surekha Trivedi, SVP, Strategy & Sustainability, sold 986 shares of common stock on August 17, 2026 at $97.05 per share in an open‑market or private transaction. Following the sale, Trivedi directly holds 8,565 shares. The transaction was effected under a previously disclosed Rule 10b5‑1 trading plan adopted on May 18, 2026.
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 13,722,619 shares of Veralto Corp common stock on a Schedule 13G, representing 5.6% of the class as of June 30, 2026. It holds sole voting power over 13,257,448 shares and sole dispositive power over all 13,722,619 shares, with no shared voting or dispositive power reported. The filer states that this report should not be construed as an admission of beneficial ownership.
Veralto Corp President and CEO Jennifer Honeycutt exercised employee stock options covering 7,097 shares of common stock at $28.767,097$101.52Rule 10b5-1 trading plan adopted on February 25, 2026. After the exercise, 7,098